We estimate that the CEO of Vir Biotechnology, Inc. ($VIR), Marianne De Backer, received a compensation of $7,834,045 in 2025. This is a decrease of -18.15% from an estimated $9,255,903 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 16, 2026. Note that parsing errors may occur.
You can track $VIR on Quiver Quantitative's $VIR stock dashboard.
$VIR Stock Insider Trading Activity
$VIR Stock insiders have traded $VIR stock on the open market 41 times in the past 6 months. Of those trades, 0 have been purchases and 41 have been sales.
Here’s a breakdown of recent trading of $VIR stock by insiders over the last 6 months:
- ENDURANCE (CAYMAN) LTD SVF has made 0 purchases and 14 sales selling 1,624,414 shares for an estimated $10,056,246.
- VICKI L SATO has made 0 purchases and 9 sales selling 174,377 shares for an estimated $1,378,335.
- BACKER MARIANNE DE (President and CEO) has made 0 purchases and 3 sales selling 106,360 shares for an estimated $946,964.
- VERNEUIL VANINA DE (EVP, General Counsel, Corp Sec) has made 0 purchases and 5 sales selling 25,012 shares for an estimated $217,684.
- BRENT SABATINI (SVP, Chief Accounting Officer) has made 0 purchases and 4 sales selling 12,500 shares for an estimated $109,505.
- JASON O'BYRNE (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 10,522 shares for an estimated $68,927.
- MARK EISNER (EVP and Chief Medical Officer) has made 0 purchases and 3 sales selling 5,594 shares for an estimated $49,523.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VIR Stock Hedge Fund Activity
We have seen 97 institutional investors add shares of $VIR Stock stock to their portfolio, and 100 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SB INVESTMENT ADVISERS (UK) LTD removed 3,567,064 shares (-21.4%) from their portfolio in Q4 2025, for an estimated $21,509,395
- BALYASNY ASSET MANAGEMENT L.P. added 1,368,474 shares (+inf%) to their portfolio in Q4 2025, for an estimated $8,251,898
- CANDRIAM S.C.A. added 1,031,663 shares (+inf%) to their portfolio in Q4 2025, for an estimated $6,220,927
- STATE STREET CORP added 988,262 shares (+18.9%) to their portfolio in Q4 2025, for an estimated $5,959,219
- ROYAL BANK OF CANADA removed 711,636 shares (-99.3%) from their portfolio in Q4 2025, for an estimated $4,291,165
- BOXER CAPITAL MANAGEMENT, LLC added 625,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,768,750
- RENAISSANCE TECHNOLOGIES LLC removed 552,636 shares (-47.4%) from their portfolio in Q4 2025, for an estimated $3,332,395
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$VIR Stock Price Targets
Multiple analysts have issued price targets for $VIR recently. We have seen 5 analysts offer price targets for $VIR in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $20.0 on 03/04/2026
- Etzer Darout from Barclays set a target price of $30.0 on 02/25/2026
- Joseph Stringer from Needham set a target price of $18.0 on 02/24/2026
- Cory Kasimov from Evercore ISI Group set a target price of $18.0 on 02/24/2026
- Michelle Gilson from Morgan Stanley set a target price of $24.0 on 02/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
